Your browser doesn't support javascript.
loading
Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy.
Chin, K; Chand, V K; Nuyten, D S A.
Affiliation
  • Chin K; Global Clinical Development Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, MA.
  • Chand VK; Global Clinical Development Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, MA.
  • Nuyten DSA; Global Product Development, Oncology, Pfizer, Inc., South San Francisco, CA, USA.
Ann Oncol ; 28(7): 1658-1666, 2017 07 01.
Article in En | MEDLINE | ID: mdl-28407031
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Antibodies, Monoclonal / Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Marruecos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Antibodies, Monoclonal / Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Marruecos Country of publication: Reino Unido